# Anixa Biosciences Inc: Form 8-K, filed May 8, 2024

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: 8-K
- Filed: 2024-05-08
- Accepted by EDGAR: May 8, 2024, 08:35 ET
- Period: 2024-05-03
- Accession: 0001493152-24-018170
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315224018170/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315224018170/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315224018170/form8-k.htm

Filed May 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-018170. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.